Astellas Pharma Share Holder Equity 2012-2025 | ALPMY

Astellas Pharma share holder equity from 2012 to 2025. Share holder equity can be defined as the sum of preferred and common equity items

Astellas Pharma Annual Share Holder Equity (Millions of US $)
2024	$10,569
2023	$11,338
2022	$11,970
2021	$12,488
2020	$11,827
2019	$11,337
2018	$11,965
2017	$11,355
2016	$10,451
2015	$11,993
2014	$12,315
2013	$11,298
2012	$12,416
2011

Astellas Pharma Quarterly Share Holder Equity (Millions of US $)
2025-06-30	$10,224
2024-06-30	$10,729
2023-06-30	$11,522
2022-06-30	$11,851
2021-06-30	$12,584
2020-06-30	$12,152
2019-06-30	$11,372
2018-06-30	$11,738
2017-06-30	$11,877
2016-09-30	$12,027
2016-06-30	$11,072
2016-03-31	$10,451
2015-12-31	$10,843
2015-09-30	$10,849
2015-06-30	$10,937
2015-03-31	$11,993
2014-12-31	$12,093
2014-09-30	$12,434
2014-06-30	$12,053
2014-03-31	$12,315
2013-12-31	$11,604
2013-09-30	$11,339
2013-06-30	$11,002
2013-03-31	$11,298
2012-12-31	$12,930
2012-09-30	$12,742
2012-06-30	$12,301
2012-03-31	$12,416
2011-12-31	$12,818

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$0.000B	$12.558B
Astellas Pharma, Inc. is engaged in the research, development, manufacturing and marketing of pharmaceuticals drugs. Products offered by the Company include Prograf applicable for the prevention of rejection in organ transplants, Vesicare for treatment of overactive bladder, Protopic for the treatment of atopic dermatitis in the topical immunomodulator class, Harnal to treat the functional symptoms of benign prostatic hyperplasia (BPH), including weak urinary stream, frequent nighttime urination, and sensation of incomplete emptying of the bladder and Fungard an antifungal agent. Astellas Pharma, Inc. is headquartered in Tokyo, Japan.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$100.311B	35.03
Takeda Pharmaceutical (TAK)	Japan	$58.739B	11.54
Zoetis (ZTS)	United States	$53.462B	19.73
BeOne Medicines - (ONC)	Switzerland	$37.951B	201.20
Sandoz Group AG (SDZNY)	Switzerland	$37.721B	0.00
Otsuka Holdings, - (OTSKY)		$37.221B	0.00
Daiichi Sankyo, - (DSNKY)	Japan	$36.542B	0.00
United Therapeutics (UTHR)	United States	$20.394B	17.95
Shionogi (SGIOY)	Japan	$19.736B	15.26
Merck (MKKGY)	Germany	$19.561B	12.06
IPSEN (IPSEY)	France	$15.077B	0.00
Ionis Pharmaceuticals (IONS)	United States	$13.055B	0.00
Neurocrine Biosciences (NBIX)	United States	$12.457B	26.92
Summit Therapeutics (SMMT)	United States	$11.536B	0.00
Orion OYJ (ORINY)	Finland	$11.214B	19.47
Madrigal Pharmaceuticals (MDGL)	United States	$10.554B	0.00
Eisai (ESAIY)		$9.636B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$8.769B	20.98
Stevanato Group S.p.A (STVN)	Italy	$4.849B	27.14
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.828B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.659B	22.12
Crinetics Pharmaceuticals (CRNX)	United States	$4.363B	0.00
Indivior Pharmaceuticals (INDV)	United States	$4.323B	17.64
Corcept Therapeutics (CORT)	United States	$4.204B	45.42
NewAmsterdam Pharma (NAMS)	Netherlands	$3.927B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.322B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$2.990B	9.54
Hypermarcas (HYPMY)	Brazil	$2.658B	18.24
Dyne Therapeutics (DYN)	United States	$2.220B	0.00
Guardian Pharmacy Services (GRDN)	United States	$2.119B	40.81
Avadel Pharmaceuticals (AVDL)	Ireland	$2.113B	0.00
Soleno Therapeutics (SLNO)	United States	$2.000B	0.00
Ocular Therapeutix (OCUL)	United States	$1.933B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.876B	22.23
Harrow (HROW)	United States	$1.766B	108.39
Ardelyx (ARDX)	United States	$1.669B	0.00
Enliven Therapeutics (ELVN)	United States	$1.586B	0.00
Oruka Therapeutics (ORKA)	United States	$1.559B	0.00
Definium Therapeutics (DFTX)	United States	$1.552B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.551B	0.00
Relay Therapeutics (RLAY)	United States	$1.548B	0.00
Nektar Therapeutics (NKTR)	United States	$1.451B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.447B	7.17
BioCryst Pharmaceuticals (BCRX)	United States	$1.425B	84.50
Evotec AG (EVO)	Germany	$1.248B	0.00
Savara (SVRA)	United States	$1.139B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.132B	0.00
Theravance Biopharma (TBPH)	United States	$0.990B	41.55
Cronos Group (CRON)	Canada	$0.988B	0.00
Aktis Oncology (AKTS)	United States	$0.900B	0.00
ARS Pharmaceuticals (SPRY)	United States	$0.875B	0.00
Xencor (XNCR)	United States	$0.828B	0.00
Esperion Therapeutics (ESPR)	United States	$0.820B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.754B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.732B	17.31
Bioventus (BVS)	United States	$0.684B	14.02
Rigel Pharmaceuticals (RIGL)	United States	$0.623B	5.56
ProKidney (PROK)	United States	$0.596B	0.00
Lyell Immunopharma (LYEL)	United States	$0.549B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.534B	0.00
Altimmune (ALT)	United States	$0.511B	0.00
Siga Technologies (SIGA)	United States	$0.486B	6.66
Zevra Therapeutics (ZVRA)	United States	$0.479B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.474B	0.00
Organogenesis (ORGO)	United States	$0.473B	0.00
Nature's Sunshine Products (NATR)	United States	$0.471B	28.03
Lexeo Therapeutics (LXEO)	United States	$0.461B	0.00
Aquestive Therapeutics (AQST)	United States	$0.445B	0.00
USANA Health Sciences (USNA)	United States	$0.382B	10.66
Aclaris Therapeutics (ACRS)	United States	$0.346B	0.00
Protara Therapeutics (TARA)	United States	$0.336B	0.00
Akebia Therapeutics (AKBA)	United States	$0.321B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.318B	0.00
Cybin (HELP)	Canada	$0.304B	0.00
Relmada Therapeutics (RLMD)	United States	$0.273B	0.00
Minerva Neurosciences (NERV)	United States	$0.271B	0.00
Avalo Therapeutics (AVTX)	United States	$0.264B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.263B	0.00
Larimar Therapeutics (LRMR)	United States	$0.261B	0.00
Journey Medical (DERM)	United States	$0.257B	0.00
OmniAb (OABI)	United States	$0.245B	0.00
Profound Medical (PROF)	Canada	$0.240B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.224B	0.00
MediWound (MDWD)	Israel	$0.222B	0.00
Context Therapeutics (CNTX)	United States	$0.211B	0.00
Heron Therapeutics (HRTX)	United States	$0.211B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.210B	0.00
Surrozen (SRZN)	United States	$0.210B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.184B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Galectin Therapeutics (GALT)	United States	$0.178B	0.00
AleAnna (ANNA)	United States	$0.171B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.157B	0.00
Century Therapeutics (IPSC)	United States	$0.153B	0.00
Prelude Therapeutics (PRLD)	United States	$0.140B	0.00
VAXART, INC (VXRT)	United States	$0.136B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.133B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.133B	0.00
Avita Medical (RCEL)	United States	$0.127B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.126B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.116B	0.00
Korro Bio (KRRO)	United States	$0.105B	0.00
Cassava Sciences (SAVA)	United States	$0.101B	0.00
Incannex Healthcare (IXHL)	Australia	$0.093B	0.00
Vivani Medical (VANI)	United States	$0.092B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.091B	0.00
Champions Oncology (CSBR)	United States	$0.084B	35.76
Pyxis Oncology (PYXS)	United States	$0.081B	0.00
Assertio Holdings (ASRT)	United States	$0.079B	0.00
PolyPid (PYPD)	Israel	$0.070B	0.00
Gain Therapeutics (GANX)	United States	$0.070B	0.00
HST Global (HSTC)	United States	$0.069B	0.00
Rafael Holdings (RFL)	United States	$0.062B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.059B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.058B	48.50
Fractyl Health (GUTS)	United States	$0.057B	0.00
BioNxt Solutions (BNXTF)	Canada	$0.057B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.056B	0.00
Dominari Holdings (DOMH)	United States	$0.055B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.053B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.051B	0.00
Nutriband (NTRB)	United States	$0.050B	0.00
Lipocine (LPCN)	United States	$0.048B	0.00
ElectroCore (ECOR)	United States	$0.043B	0.00
Lite Strategy (LITS)	United States	$0.041B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Plus Therapeutics (PSTV)	United States	$0.038B	0.00
Talphera (TLPH)	United States	$0.038B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.037B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
SCYNEXIS (SCYX)	United States	$0.031B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.030B	0.00
TherapeuticsMD (TXMD)	United States	$0.027B	0.00
Wellgistics Health (WGRX)	United States	$0.025B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.024B	0.00
Natural Alternatives (NAII)	United States	$0.022B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.020B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.018B	0.00
Scienture Holdings (SCNX)	United States	$0.018B	0.00
Klotho Neurosciences (KLTO)	United States	$0.016B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.016B	0.00
Traws Pharma (TRAW)	United States	$0.015B	0.02
Iterum Therapeutics (ITRM)	Ireland	$0.015B	0.00
Vyome Holdings (HIND)	United States	$0.015B	0.00
Cosmos Health (COSM)	United States	$0.014B	0.00
Vivos Therapeutics (VVOS)	United States	$0.014B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
BioLineRx (BLRX)	Israel	$0.013B	0.00
Liminatus Pharma (LIMN)	United States	$0.012B	0.00
Tempest Therapeutics (TPST)	United States	$0.012B	0.00
CASI Pharmaceuticals (CASI)	China	$0.010B	0.00
Inotiv (NOTV)	United States	$0.010B	0.00
BioVie (BIVI)	United States	$0.010B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.009B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.008B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Ainos (AIMD)	United States	$0.007B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.007B	0.00
Biomerica (BMRA)	United States	$0.007B	0.00
Nuvilex (PMCB)	United States	$0.007B	0.00
Mangoceuticals (MGRX)	United States	$0.006B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.006B	0.00
Redhill Biopharma (RDHL)	Israel	$0.005B	0.00
Heatwurx (PCSA)	United States	$0.005B	0.00
Xenetic Biosciences (XBIO)	United States	$0.005B	0.00
Aptorum Group (APM)	United Kingdom	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.005B	0.00
Indaptus Therapeutics (INDP)	United States	$0.004B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.004B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.003B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.003B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.003B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.003B	0.00
Lyra Therapeutics (LYRA)	United States	$0.002B	0.00
Jaguar Animal Health (JAGX)	United States	$0.002B	0.00
SciSparc (SPRC)	Israel	$0.002B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
Clearmind Medicine (CMND)	Canada	$0.002B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
PainReform (PRFX)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.000B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
Grifols, S.A (GRFS)	Spain	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00